TMCnet News

Research and Markets: Boceprevir - Comprehensive Patent Search Service 2015
[February 27, 2015]

Research and Markets: Boceprevir - Comprehensive Patent Search Service 2015


Research and Markets (http://www.researchandmarkets.com/research/df98hz/boceprevir) has announced the addition of the "Boceprevir - Comprehensive patent search" report to their offering.

Imagine having your own team of pharmaceutical patent experts at the click of a button.

Used by the world's leading pharmaceutical companies and legal teams for over 10 years, these searches are the benchmark in comprehensive, accurate and relevant patent data. Searched and analysed b highly trained, qualified staff using proprietary searching techniques, you won't need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on your business, rather than getting bogged down in patent data.



This report covers:

  • International Nonproprietary Name: Boceprevir
  • indications: Treatment of chronic hepatitis C (CHC) genotype 1, in combination with Peginterferon alfa and Ribavirin
  • innovator:Merck (Victrelis)

Country coverage:


The In-depth search contains patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents.

Access:

This report is provided through an online portal for a period of 12 months, for a maximum of 5 users. During this period, access to updates, excel exports, patent documents and national registers is provided at no additional charge.

For more information visit http://www.researchandmarkets.com/research/df98hz/boceprevir


[ Back To TMCnet.com's Homepage ]